Skip to content

C81.00 ICD-10-CM Code: Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site

C81.00 maps to CMS-HCC V28 21. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC81.00

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

C81.00

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site

A specific type of Hodgkin lymphoma (blood cancer) characterized by nodular lymphocyte predominance, affecting lymph nodes but the specific location is not documented.

Buddy the Bee presenting code insight

Buddy Insight

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) at an unspecified site is a distinct subtype of Hodgkin lymphoma characterized by 'popcorn cells' (lymphocyte-predominant cells) rather than classic Reed-Sternberg cells.

CMS-HCC V28

HCC 21

Coefficient HCC 21: 0.671 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Historical

Not used for CY2026 payment

ACA/HHS

HCC 012

Code-level coefficient reference

ESRD/PACE

HCC 10

Code-level coefficient reference

RXHCC

HCC 21

Code-level coefficient reference

Inclusion Terms

Official

No inclusion terms are included in this display for C81.00. Check the code and parent instructions in the Code Book.

Excludes 2

Official
  • Kaposi's sarcoma of lymph nodes (C46.3)Inherited from C81-C96
  • secondary and unspecified neoplasm of lymph nodes (C77.-)Inherited from C81-C96
  • secondary neoplasm of bone marrow (C79.52)Inherited from C81-C96
  • secondary neoplasm of spleen (C78.89)Inherited from C81-C96

Includes

Official

No Includes notes are included in this display for C81.00. Check the code and parent instructions in the Code Book.

Excludes 1

Official
  • personal history of Hodgkin lymphoma (Z85.71)Inherited from C81

Code First

Official

No Code First sequencing instructions are included in this display for C81.00. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for C81.00. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for C81.00. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance
Pathology report confirming nodular lymphocyte predominant subtype (not classic Hodgkin lymphoma)
Immunohistochemistry showing CD20+, CD15-, CD30- pattern (differentiates from classic Hodgkin)
Staging workup (Ann Arbor staging system)
Documentation of involved lymph node site(s) — query for specificity to avoid unspecified code

MEAT Support

HCC Buddy guidance
Pathology report confirming nodular lymphocyte predominant subtype (not classic Hodgkin lymphoma)
Immunohistochemistry showing CD20+, CD15-, CD30- pattern (differentiates from classic Hodgkin)
Staging workup (Ann Arbor staging system)
Documentation of involved lymph node site(s) — query for specificity to avoid unspecified code

Audit Caution

HCC Buddy guidance
Using this unspecified site code when the lymph node location is documented elsewhere in the record
Confusing NLPHL with nodular sclerosis Hodgkin lymphoma — these are distinct entities with different prognosis and treatment
Not recognizing that NLPHL has a distinct immunophenotype (CD20+) that differs from classic Hodgkin lymphoma (CD15+/CD30+)
Failing to code this as Hodgkin lymphoma when pathology uses the older term 'nodular paragranuloma'

Common Mistakes

HCC Buddy guidance
C81.10-C81.19 — Nodular sclerosis Hodgkin lymphoma: Most common classic Hodgkin subtype; completely different histology and immunophenotype from NLPHL
C81.01-C81.09 — Site-specific NLPHL codes: Use these more specific codes when the lymph node location is documented
C85.10 — Unspecified B-cell lymphoma: NLPHL is a B-cell neoplasm but has its own specific coding
C81.0A — NLPHL in remission: Use when remission status is documented

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C81.00 an HCC code?

Yes. C81.00 (Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site) maps to HCC 21, Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.671. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: C81.00 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
C81.00
Description
Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site
HCC (V28)
HCC 21 — Lymphoma and Other Cancers
RAF reference coefficient
0.671
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 21, Lymphoma and Other Cancers
0.671
ESRDHCC 10, Lymphoma and Other Cancers
Not separately weighted
RxHCCHCC 21, Lymphomas and Other Hematologic Cancers
Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work C81.00 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for C81.00

For C81.00, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C81.00 is the ICD-10-CM diagnosis code for nodular lymphocyte predominant hodgkin lymphoma, unspecified site. A specific type of Hodgkin lymphoma (blood cancer) characterized by nodular lymphocyte predominance, affecting lymph nodes but the specific location is not documented. C81.00 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lymphoid, hematopoietic and related tissue (c81-c96).

Under the CMS-HCC V28 risk adjustment model, C81.00 maps to Lymphoma and Other Cancers (HCC 21) with a source-labeled community, non-dual, aged reference coefficient of 0.671. No V24 mapping is shown for C81.00; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

If lymph node location is documented, use a more specific code (C81.01-C81.09) rather than C81.00. For C81.00, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C81.00 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • If lymph node location is documented, use a more specific code (C81.01-C81.09) rather than C81.00
  • Verify pathology report confirms nodular lymphocyte predominant subtype

Clinical Significance

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) at an unspecified site is a distinct subtype of Hodgkin lymphoma characterized by 'popcorn cells' (lymphocyte-predominant cells) rather than classic Reed-Sternberg cells. NLPHL accounts for approximately 5% of all Hodgkin lymphoma cases, tends to present at an early stage, and has an excellent long-term prognosis with greater than 90% 10-year survival. However, it carries a risk of late relapse and potential transformation to aggressive non-Hodgkin lymphoma.

Documentation Requirements

  • Pathology report confirming nodular lymphocyte predominant subtype (not classic Hodgkin lymphoma)
  • Immunohistochemistry showing CD20+, CD15-, CD30- pattern (differentiates from classic Hodgkin)
  • Staging workup (Ann Arbor staging system)
  • Documentation of involved lymph node site(s) — query for specificity to avoid unspecified code
  • Treatment approach (watch-and-wait for Stage IA, radiation, rituximab, or chemotherapy)
  • B-symptoms status (fever, night sweats, weight loss)

Commonly Confused Codes

  • C81.10-C81.19: Nodular sclerosis Hodgkin lymphoma: Most common classic Hodgkin subtype; completely different histology and immunophenotype from NLPHL
  • C81.01-C81.09: Site-specific NLPHL codes: Use these more specific codes when the lymph node location is documented
  • C85.10: Unspecified B-cell lymphoma: NLPHL is a B-cell neoplasm but has its own specific coding
  • C81.0A: NLPHL in remission: Use when remission status is documented

Child Codes

Code Hierarchy

Also searched as

  • C81 00
  • C8100

For C81.00, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

C81.00 maps to CMS-HCC V28 category 21, Lymphoma and Other Cancers. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. The mapping identifies a payment HCC category for C81.00. Review its source-labeled HCC coefficient above, check the RAF Calculator with complete member context for CMS-HCC V28 PY2026, and confirm the documentation the chart needs before the code is submitted. HCC Buddy shows no RAF score unless every required source and calculation check passes.

Work C81.00 in HCC Buddy

Open C81.00 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.